I

Inversago Pharma Inc

5 employees

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Pharmaceutical
Biopharma
Medical
Health Care

Date founded

2015

Funding rounds raised

Total raised

$69M

from 15 investors over 15 rounds

I

Inversago Pharma Inc raised $69M on October 17, 2022

Investors: adMare BioInnovations, Forbion, Genesys Capital and JDRF T1D Fund

I

Inversago Pharma Inc raised $35M on September 8, 2020

Investors: adMare BioInnovations, AQC Capital, Genesys Capital, JDRF T1D Fund and Forbion

I

Inversago Pharma Inc raised $7M on July 25, 2018

Investors: Anges Québec, Tarnagulla Ventures, Accel-Rx - Canada's Health Science Accelerator, JDRF T1D Fund, Genesys Capital and AQC Capital

FAQ